Philippe Dufresne1, Lynne Moore1, Pier-Alexandre Tardif1, Tarek Razek1, Madiba Omar1, Amélie Boutin1, Julien Clément1. 1. From the Population Health and Optimal Health Practices Research Unit, Trauma, Emergency, Critical Care Medicine, CHU de Québec, Université Laval Research Centre, Québec, Que., (Dufresne, Moore, Tardif, Omar, Boutin); the Department of Social and Preventive Medicine, Université Laval, Québec, Que., (Dufresne, Moore, Tardif, Omar, Boutin); the Department of Sugery, McGill University, Montreal, Que., (Razek); and the Department of Surgery, Université Laval, Québec, Que. (Clément).
Abstract
BACKGROUND: Hemorrhagic shock is responsible for 45% of injury fatalities in North America, and 50% of these occur within 2 h of injury. There is currently a lack of evidence regarding the trajectories of patients in hemorrhagic shock and the potential benefit of level I/II care for these patients. We aimed to compare mortality across trauma centre designation levels for patients in hemorrhagic shock. Secondary objectives were to compare surgical delays, complications and hospital length of stay (LOS). METHODS: We performed a retrospective cohort study based on a Canadian inclusive trauma system (1999-2012), including adults with systolic blood pressure (SBP) < 90 mm Hg on arrival who required urgent surgical care (< 6 h). Logistic regression was used to examine the influence of trauma centre designation level on risk-adjusted surgical delays, mortality and complications. Linear regression was used to examine LOS. RESULTS: Compared with level I centres, adjusted odds ratios (and 95% confidence intervals [CI]) of mortality for level III and IV centres were 1.71 (1.03-2.85) and 2.25 (1.08-4.73), respectively. Surgical delays did not vary across designation levels, but mean LOS and complications were lower in level II-IV centres than level I centres. CONCLUSION: Level I/II centres may offer a survival advantage over level III/IV centres for patients requiring emergency intervention for hemorrhagic shock. Further research with larger sample sizes is required to confirm these results and to identify optimal transport time thresholds for bypassing level III/IV centres in favour of level I/II centres.
BACKGROUND: Hemorrhagic shock is responsible for 45% of injury fatalities in North America, and 50% of these occur within 2 h of injury. There is currently a lack of evidence regarding the trajectories of patients in hemorrhagic shock and the potential benefit of level I/II care for these patients. We aimed to compare mortality across trauma centre designation levels for patients in hemorrhagic shock. Secondary objectives were to compare surgical delays, complications and hospital length of stay (LOS). METHODS: We performed a retrospective cohort study based on a Canadian inclusive trauma system (1999-2012), including adults with systolic blood pressure (SBP) < 90 mm Hg on arrival who required urgent surgical care (< 6 h). Logistic regression was used to examine the influence of trauma centre designation level on risk-adjusted surgical delays, mortality and complications. Linear regression was used to examine LOS. RESULTS: Compared with level I centres, adjusted odds ratios (and 95% confidence intervals [CI]) of mortality for level III and IV centres were 1.71 (1.03-2.85) and 2.25 (1.08-4.73), respectively. Surgical delays did not vary across designation levels, but mean LOS and complications were lower in level II-IV centres than level I centres. CONCLUSION: Level I/II centres may offer a survival advantage over level III/IV centres for patients requiring emergency intervention for hemorrhagic shock. Further research with larger sample sizes is required to confirm these results and to identify optimal transport time thresholds for bypassing level III/IV centres in favour of level I/II centres.
Authors: J S Sampalis; R Denis; A Lavoie; P Fréchette; S Boukas; A Nikolis; D Benoit; D Fleiszer; R Brown; M Churchill-Smith; D Mulder Journal: J Trauma Date: 1999-04
Authors: Joseph P Minei; Timothy C Fabian; Danielle M Guffey; Craig D Newgard; Eileen M Bulger; Karen J Brasel; Jason L Sperry; Russell D MacDonald Journal: Ann Surg Date: 2014-09 Impact factor: 12.969
Authors: Ari M Lipsky; Marianne Gausche-Hill; Philip L Henneman; Anthony J Loffredo; Patricia B Eckhardt; H Gill Cryer; Christian de Virgilio; Stanley L Klein; Frederic S Bongard; Roger J Lewis Journal: J Trauma Date: 2006-11
Authors: Lynne Moore; Henry Thomas Stelfox; Alexis F Turgeon; Avery Nathens; Gilles Bourgeois; Jean Lapointe; Mathieu Gagné; André Lavoie Journal: Ann Surg Date: 2014-07 Impact factor: 12.969